| Model Number |
11400M |
| Medical Device Problem Codes |
Patient-Device Incompatibility (2682); Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Laceration(s) (1946); Rupture (2208)
|
| Date of Event |
11/21/2025
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
H11: additional manufacturer narrative: the investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
|
| |
|
Event or Problem Description
|
|
It was reported that a patient with a 29 mm 11400 m mitral valve was explanted at implant due to annular tear seen on post-bypass echo.The tear was fixed with a patch, and the explanted valve was replaced with a 27 mm 11400 m valve.
|
| |
|
Additional Manufacturer Narrative
|
|
H11: additional manufacturer narrative: updated sections b5, g3, g6, h2.H11: corrected data: h6 (clinical code).
|
| |
|
Event or Problem Description
|
|
It was reported and learned by records provided that patient with a 29mm 11400m mitral valve was explanted at implant due to bleeding caused by av groove disruption.The tear was fixed with a patch, and the explanted valve was replaced with a 27mm 11400m valve.Per records provided, after implanting the 29mm mitris valve it was discovered that there was a large amount of bright red blood pooling from the bottom of the valve.After careful examination it was revealed a focal av groove disruption.Therefore, it was decided to remove the valve, and it was noted that one of the annular stitches had pulled through and created a focal defect in the posterior atrial wall near p2.A 27mm 11400m valve was implanted in replacement.Intraoperative tee demonstrated a well seated valve with a mean transvalvular gradient of 1 mmhg.The patient tolerated the procedure well and was taken to icu for further recovery.
|
| |
|
Additional Manufacturer Narrative
|
|
H11: additional manufacturer narrative: updated sections g3, g6, h2, h6 (type of investigation, investigation findings, investigation conclusions).Av disruption (disassociation) is a dreaded and often fatal complication.This is an extreme form of posterior left ventricular (lv) rupture where a portion or the entire posterior left atrium separates from the lv.Av disruption (disassociation) is usually related to vigorous traction or debridement of the posterior leaflet of the mitral valve or excessive decalcification of a calcified mitral annulus.This can cause separation of the av groove, leading to massive hemorrhage upon separation from cardiopulmonary bypass.There is no evidence to suggest a manufacturing defect caused or contributed to the reported event.Based on the information available, the most likely cause is patient and/or procedural factors.Device was discarded.The instructions for use (ifu) have been reviewed, and no inadequacies have been identified regarding warnings, contraindications, and the directions/conditions for the successful use of the device.The reported type of event is included in the ifu.The device history record (dhr) was not reviewed as the reported event does not allege a malfunction that could be related to an edwards manufacturing deficiency and/or one was not suspected or confirmed through investigation, no labeling non-conformance/deficiency; no use-related issue with a hazardous situation; no device-related infection; and no evidence of a product failure with regard to design, reliability, or use error.Edwards will continue to review and monitor all events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.If new information becomes available, a supplemental report will be submitted.H11: corrected data: corrected section h6 (device code).
|
| |
|
Search Alerts/Recalls
|